e-Drug3D

688

DIDANOSINE

DISCONTINUED


INN
DIDANOSINE

(has an active metabolite)

cas 69655-05-6
CLASS

ANTIINFECTIVES
ANTIVIRAL
ANTI-HIV AGENTS
ANTIMETABOLITES
REVERSE TRANSCRIPTASE INHIBITORS

ROUTE (list)

ORAL

ATC code

J05AF02

PK parameters

F 42 PERCENT
Tmax 0.8 HOUR
VD 70.3 LITER
Cl 50 LITER / HOUR
PPB 5 PERCENT
t1/2 1.5 HOUR

Solubility

IN WATER 27.3 MILLIGRAM / MILLILITER (PH=6)


Target

TARGET REVERSE TRANSCRIPTASE (GAG-POL POLYPROTEIN)

DrugCentral

Reverse transcriptase,RNaseH UNIPROT Q72549 pol

Download SDF file 9-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one

Formula:
C10H12N4O3

Calculated chemical properties:

MW 236.24
NB_atoms 17
XLogP -0.21
PSA 87.326
NB_HD 2
NB_HA 7
fsp3 0.50
Lipinski(0=no;1=yes) 1

FDA
NDA 020154 (pdf not found) INN (DIDANOSINE) VIDEX (BRISTOL MYERS SQUIBB) APPROVAL= AP YEAR= 1991 DISCONTINUED
NDA 020155 (pdf not found) INN (DIDANOSINE) VIDEX (BRISTOL MYERS SQUIBB) APPROVAL= AP YEAR= 1991 DISCONTINUED
NDA 020156 (pdf not found) INN (DIDANOSINE) VIDEX (BRISTOL) APPROVAL= AP YEAR= 1991 DISCONTINUED
NDA 021183 (pdf not found) INN (DIDANOSINE) VIDEX EC (BRISTOL MYERS SQUIBB) APPROVAL= AP YEAR= 2000 DISCONTINUED
NDA 077167 (pdf not found) INN (DIDANOSINE) DIDANOSINE (BARR) APPROVAL= AP YEAR= 2004 DISCONTINUED
NDA 078112 (pdf not found) INN (DIDANOSINE) DIDANOSINE (AUROBINDO PHARMA) APPROVAL= AP YEAR= 2007 DISCONTINUED
NDA 090094 (pdf not found) INN (DIDANOSINE) DIDANOSINE (AUROBINDO PHARMA) APPROVAL= AP YEAR= 2008 DISCONTINUED
NDA 090788 (pdf not found) INN (DIDANOSINE) DIDANOSINE (PHARMOBEDIENT) APPROVAL= AP YEAR= 2010 DISCONTINUED
NDA 077275 (pdf not found) INN (DIDANOSINE) DIDANOSINE (AUROBINDO) APPROVAL= AP YEAR= 2012 DISCONTINUED

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL